SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations
Francesca Mateo(Institut d'Investigació Biomédica de Bellvitge), Timothy M. Thomson(Universidad Peruana Cayetano Heredia), Begoña Mellado(Hospital Clínic de Barcelona), Simó Schwartz(CIBBIM-Nanomedicine), Óscar Meca‐Cortés(Institut de Biologia Molecular de Barcelona), Lourdes Mengual(Hospital Clínic de Barcelona), Amaia Sagasta(Hospital Clínic de Barcelona), Ibane Abasolo(Unknown), Leonardo Rodríguez‐Carunchio(Hospital Clínic de Barcelona), Pedro L. Fernández, Toni Celià-Terrassa(Princeton University), Rosanna Paciucci(Vall d'Hebron Institut de Recerca), Antonio Alcaraz(Hospital Clínic de Barcelona), Kristina Y. Aguilera(University of California, Los Angeles), Raquel Bermudo(Hospital Clínic de Barcelona), Mercedes Marín‐Aguilera(Oryzon Genomics (Spain)), Rolf A. Brekken(Southwestern Medical Center), Yolanda Fernández(CIBBIM-Nanomedicine), Verónica Cánovas(Vall d'Hebron Institut de Recerca), Mònica Pons(Institut de Biologia Molecular de Barcelona), Lourdes Sánchez‐Cid(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer)
Cited by 73
Related Papers
Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells
|Journal of Clinical Investigation|2012|462
Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution
|JCI Insight|2019|281
Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks
|Genome Research|2016|278
Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.
|Proceedings of the National Academy of Sciences|1984|273